Featured
Featured Videos
Julianna LeMieux, PhD, GEN’s Deputy Editor-in-Chief took a minute away from the talks, posters, and expo hall to join Uduak Thomas, Senior Editor at GEN, who is also in Denver, to talk about the meeting, the sessions they attended, and the trends that they are noticing. Some of the highlights were an interview with Jacob Thaysen, Illumina’s new CEO, a single cell initiative, how proteomics is trying to change Alzheimer’s detection, and the launch of PacBio’s new instrument—the Vega—complete with a review of the OneRepublic concert.
Genomics in Snowy Denver: A Video Update from ASHG
John Sterling, GEN’s Editor-in-Chief, has been attending BPI since its inception, 20 years ago! Here, he took a minute away from the talks and posters to join Julianna LeMieux, PhD, Deputy Editor-in-Chief—who was at BPI for her second time—to talk about the first day of the meeting, the sessions they attended, and the trends that they are noticing. John also reflects on 20 years in the industry.
Bioprocessing in Boston: GEN Reports Live from BPI 2024
In the February issue of GEN, we were thrilled to speak with Eric Green, MD, PhD, about the 25th anniversary of AGBT—the premier genomics conference happening later this month in Marco Island, Florida. Green, who has attended every AGBT meeting to date, filled us in on the history of the meeting, the significance of the silver anniversary, and the ups and downs over the years. Other topics covered in the February issue include optimizing AAV capsids for delivery and how agriculture companies are looking to gene editing to create resilient crops for the future. In addition, Alex Philippidis, GEN’s senior business editor, included his A-list on the Top 10 Takeover Targets of 2025.
